Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (50%) |
| §102 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOHANSEN, PETER N. | 1 | 58.9% | +24.3% |
| HALVORSON, MARK | 1 | 48.1% | +21.6% |
| AEDER, SEAN E | 1 | 56.9% | +19.9% |
| DUNN, MCKENZIE A | 1 | 53.8% | +55.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18249957 | PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT | AEDER, SEAN E | 46d overdue |
| 18185632 | PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT | DUNN, MCKENZIE A | 30d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18249957 | PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT | AEDER, SEAN E | 46d overdue |
| 18185632 | PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT | DUNN, MCKENZIE A | 30d overdue |
| 18572125 | ANTI-TIGIT AND ANTI-PVRIG IN MONOTHERAPY AND COMBINATION TREATMENTS | JOHANSEN, PETER N. | — |
| 18452985 | ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF | HALVORSON, MARK | — |
| Art Unit | Apps |
|---|---|
| 1644 | 1 |
| 1646 | 1 |
| 1642 | 1 |
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18572125 | ANTI-TIGIT AND ANTI-PVRIG IN MONOTHERAPY AND COMBINATION TREATMENTS | JOHANSEN, PETER N. | 1644 | §103DP | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18452985 | ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF | HALVORSON, MARK | 1646 | §102Other | Final Rejection | — | Pending | Aug 21, 2023 |
| 18249957 | PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT | AEDER, SEAN E | 1642 | §101§103§112Other | Non-Final OA | 46d overdue | Pending | Apr 20, 2023 |
| 18185632 | PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT | DUNN, MCKENZIE A | 1678 | §101§102§103§112Other | Non-Final OA | 30d overdue | Pending | Mar 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial